Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk’s Drug May Avoid Takeda’s FDA Travails
Novo Nordisk’s Drug May Avoid Takeda’s FDA Travails
Novo Nordisk’s Drug May Avoid Takeda’s FDA Travails
Submitted by
admin
on March 26, 2009 - 7:09am
Source:
Bloomberg
News Tags:
Novo Nordisk
FDA
Takeda
diabetes
liraglutide
Headline:
Novo Nordisk’s Drug May Avoid Takeda’s FDA Travails
Do Not Allow Advertisers to Use My Personal information
